nach oben

Medical Oncology

Erschienen in:

01.09.2012 | Short Communication

Additional chromosomal abnormalities detected by array comparative genomic hybridization in AML

verfasst von: Ana Rosa S. Costa, Sintia I. Belangero, Maria Isabel Melaragno, Maria de Lourdes Chauffaille

Erschienen in: Medical Oncology | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Improved outcome of acute myeloid leukemia (AML) depends on the better differentiation of subtypes to predict treatment response and the identification of new target for treatment. In this study, array comparative genomic hybridization (aCGH) was used to distinguish eight cases of AML cases. Validation was performed by FISH and quantitative genomic PCR. The aCGH revealed new large and small recurrent genomic imbalances, such as gains of 1p36, 10q26, 11p15, 20q13, 22q23, harboring many proto-oncogenes. These results better define genetically the studied cases and could be used to understand the multiple phenomena involved in leukemogenesis.

Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1, 612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children’s Leukaemia Working Parties. Blood. 1998;92:2322–33.PubMed

Mrozek K, Bloomfield CD. Chromosome aberrations, gene mutations and expression changes, and prognosis in adult acute myeloid leukemia. Hematol Am Soc Hematol Educ Program. 2006;169–177.

Shinawi M, Cheung SW. The array CGH and its clinical applications. Drug Discov Today. 2008;13:760–70.PubMedCrossRef

Maciejewski JP, Mufti GJ. Whole genome scanning as a cytogenetic tool in hematologic malignancies. Blood. 2008;112:965–74.PubMedCrossRef

Shaffer LG, Slovak ML, Campbell LJ, editors. ISCN 2009: an international system for human cytogenetic nomenclature 2009. Basel: S. Karger; 2009.

Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, Scherer SW, Lee C. Detection of large-scale variation in the human genome. Nat Genet. 2004;36:949–51.PubMedCrossRef

Andersen MK, Christiansen DH, Kirchhoff M, et al. Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents. Genes Chromosomes Cancer. 2001;31:33–41.PubMedCrossRef

Gao C, Chen YG. Dishevelled: the hub of Wnt signaling. Cell Signal. 2010;22:717–27.PubMedCrossRef

Reya T, Clevers H. Wnt signaling in stem cells and cancer. Nature. 2005;434:843–50.PubMedCrossRef

10.

Garnis C, Campbell J, Davies JJ, Macaulay C, Lam S, Lam WL. Involvement of multiple developmental genes on chromosome 1p in lung tumorigenesis. Hum Mol Genet. 2005;14:475–82.PubMedCrossRef

11.

Vasikova A, Budinska E, Belickova M, Cermak J, Bruchova H. Differential gene expression of bone marrow CD34+ cells in early and advanced myelodysplastic syndrome. Neoplasma. 2009;56:335–42.PubMedCrossRef

12.

Feuk L, Carson AR, Scherer SW. Structural variation in the human genome. Nat Rev Genet. 2006;7:85–97.PubMedCrossRef

13.

Starczynowski DT, Vercauteren S, Sung S, et al. Copy number alterations at polymorphic loci may be acquired somatically in patients with myelodysplastic syndromes. Leuk Res. 2010;35:444–7.CrossRef

Titel: Additional chromosomal abnormalities detected by array comparative genomic hybridization in AML
verfasst von: Ana Rosa S. Costa
Sintia I. Belangero
Maria Isabel Melaragno
Maria de Lourdes Chauffaille
Publikationsdatum: 01.09.2012
Verlag: Springer US
Erschienen in: Medical Oncology / Ausgabe 3/2012
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI: https://doi.org/10.1007/s12032-011-0108-5

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Additional chromosomal abnormalities detected by array comparative genomic hybridization in AML

Abstract

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

Risk of nasopharyngeal carcinoma associated with polymorphic lactotransferrin haplotypes

Unexpected effect of the monoclonal antibody Panitumumab on human cancer cells with different KRAS status

The relationship between Bmi-1 and the epithelial–mesenchymal transition in lung squamous cell carcinoma

Phase I clinical trial of continuous infusion of tyroserleutide in patients with advanced hepatocellular carcinoma

Association of clinical and pathological variables with survival in thymoma

The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie